Carebastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C32H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75DLN707DO, chemically known as benzeneacetic acid, 4-(4-(4-(diphenylmethoxy)-1-piperidinyl)-1-oxobutyl)-alpha,alpha-dimethyl- but generally known as carebastine, which bears US NIH Compound Identifier 65820. European Medicines Agency schedules Carebastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06623MIG. The term CAREBASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). CAREBASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carebastine under HS 29333999 and SITC 51574. As of Q4 2014, CAREBASTINE remains the US FDA Preferred Term for this commodity. Carebastine bears US NLM identifiers UMLS ID C0209013 and NCI Concept Code C77432. SMILES: O(C1CCN(CC1)CCCC(=O)C1CCC(C(C)(C)C(=O)O)CC1)C(C1CCCCC1)C1CCCCC1.